ALVO (Alvotech) Earnings per share growth rate in current year
Alvotech (ALVO) growth is underpinned by its impeccable reputation as a developer of affordable biosimilars with rigorous quality control. The year-over-year volatility of earnings per share visualizes this trend, while the 89.20 metric confirms the current level. This is supported by Robert Wessman's strategy to demonopolize the market and the implementation of autonomous bioreactors with precision filling lines.
Comprehensive metric breakdowns and analytics for Alvotech (ALVO)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
- net income and valuation multiples indicators:
ALVO - Net Profit|Future Profit Alvotech|ALVO - P/E Multiple|Future Price to Earnings Multiple Alvotech Biopharmaceuticals|ALVO - PEG Multiple|EV/EBITDA Multiple Alvotech Biopharmaceuticals|ALVO - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Alvotech|ALVO - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months alvotech.com|ALVO - Earnings per share growth in current year|Expected net earnings per share growth next year Alvotech
Basic company analysis:ALVO Alvotech S.A.
The stability of Alvotech (ALVO) European production capacities and the absence of trade barriers in the biosimilars sector are reflected in the annual EPS growth rate. This indicator compares current earnings per share with the same period last year, allowing investors to perform a real-time assessment of the business's fundamental resilience and avoid freezing capital during periods of market volatility.
Key competitors
Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal)|Earnings growth in current year Perrigo Company PLC PRGO|LQDA - Earnings per share growth in current year|GLPG: Earnings per share growth in current year|ANIP (ANI Pharmaceuticals) - Net earnings per share growth this year|MNKD (mannkindcorp.com) - Earnings per share growth in current year|Earnings per share growth in current year Amphastar Pharmaceuticals, Inc.|Earnings per share growth rate in current year Pacira Pharmaceuticals PCRX|Net earnings per share growth this year SPRY (ARS Pharma)|Net earnings per one share growth for the current year TBPH|Earnings growth in current year AQST (Aquestive Therapeutics)|scPharmaceuticals, Inc. (SCPH) - Earnings per share growth rate in current year|Tectonic - Earnings growth in current year|Tonix Pharma (TNXP) - Net earnings per share growth this year|SXTC: Earnings growth in current year|Eupraxia Pharmaceuticals Inc. - Earnings per share increase in current year|BHST (BioHarvest Sciences) - Earnings growth in current year|Earnings growth in current year invizyne.com|Earnings per share growth in current year Oramed Pharmaceuticals (ORMP)|Earnings per share growth in current year ENTX (enterabio.com)|MindWalk - Net earnings per share growth this year|ABVC BioPharma, Inc - Earnings per share growth in current year|CPIX - Earnings per share growth in current year|Earnings per share growth rate in current year quantumbiopharma.com|FibroGen (FGEN) - Earnings per share growth in current year|Earnings per share trend in current year TELO (Telomir Pharmaceuticals Inc)|RANI (Rani Therapeutics Holdings) - Earnings growth in current year|SNYR: Earnings per share increase in current year|Earnings growth in current year RLYB|Earnings growth in current year lexariabioscience.com (LEXX)|Earnings per share growth in current year Pulmatrix PULM|Earnings per share increase in current year PTHL|APM - Earnings per share growth in current year|Lyra Therapeutics Inc (LYRA) - Net earnings per share growth this year|IBO: Earnings growth in current year|TNF Pharmaceuticals, Inc. (TNFA) - Earnings growth in current year|Net earnings per share growth this year YCBD|PRFX: Earnings per share increase in current year|Earnings per share growth in current year Altamira Therapeutics (CYTO)|LIPO - Earnings per share growth rate in current year|OptiNose, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year PIRS (pieris.com)|Procaps - Earnings growth in current year|Earnings per share increase in current year PTPI (Petros Pharmaceuticals Inc)|QLI: Earnings growth in current year|Earnings per share growth rate in current year ACELYRIN Inc. (SLRN)|Earnings per share growth in current year TFF Pharmaceuticals
